Farther Finance Advisors, LLC

Position in HIMS — Hims & Hers Health, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in HIMS

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$432,327

-$218,923 QoQ

Shares Held

20,825

+3.8% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $5,648,119 across 52 Drug Manufacturers - Specialty & Generic names. HIMS ranks #4 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	11,645	$1,376,555
2	VTRS	Viatris Inc	43,117	$582,510
3	UTHR	UNITED THERAPEUTICS Corp	818	$485,057
4	HIMS	Hims & Hers Health, Inc. This page	20,825	$432,327
5	NBIX	Neurocrine Biosciences Inc	2,947	$388,237
6	COLL	Collegium Pharmaceutical, Inc	11,677	$386,158
7	TEVA	Teva Pharmaceutical Industries Ltd	11,152	$335,898
8	TAK	Takeda Pharmaceutical Co Ltd	17,828	$330,174

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$432,327	20,825	+3.8%	Shares	Sole	2026-04-07
2025-12-31	$651,250	20,057	+5.5%	Shares	Sole	2026-01-23
2025-09-30	$1,077,963	19,005	+121.4%	Shares	Sole	2025-10-14
2025-06-30	$427,912	8,584	+5.7%	Shares	Sole	2025-07-11
2025-03-31	$240,005	8,122	+12.9%	Shares	Sole	2025-04-14
2024-12-31	$173,902	7,192	+1.0%	Shares	Sole	2025-02-10
2024-09-30	$131,150	7,120	+0.6%	Shares	Sole	2024-10-29
2024-06-30	$142,844	7,075	0.0%	Shares	Sole	2024-07-31
2024-03-31	$109,450	7,075	+9333.3%	Shares	Sole	2024-05-14
2023-12-31	$667	75	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.